|
1
|
Pennathur A, Gibson MK, Jobe BA and
Luketich JD: Oesophageal carcinoma. Lancet. 381:400–412. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y,
Ueda J, Wei W, Inoue M and Tanaka H: Epidemiology of esophageal
cancer in Japan and China. J Epidemiol. 23:233–242. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chua KN, Poon KL, Lim J, Sim WJ, Huang RY
and Thiery JP: Target cell movement in tumor and cardiovascular
diseases based on the epithelial-mesenchymal transition concept.
Adv Drug Deliv Rev. 63:558–567. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
De Craene B and Berx G: Regulatory
networks defining EMT during cancer initiation and progression. Nat
Rev Cancer. 13:97–110. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weidle UH, Scheuer W, Eggle D, Klostermann
S and Stockinger H: Cancer-related issues of CD147. Cancer Genomics
Proteomics. 7:157–169. 2010.PubMed/NCBI
|
|
7
|
Toole BP: Emmprin (CD147), a cell surface
regulator of matrix metalloproteinase production and function. Curr
Top Dev Biol. 54:371–389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ru NY, Wu J, Chen ZN and Bian H:
HAb18G/CD147 is involved in TGF-β-induced epithelial-mesenchymal
transition and hepatocellular carcinoma invasion. Cell Biol Int.
39:44–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vlotides G, Eigler T and Melmed S:
Pituitary tumor-transforming gene: Physiology and implications for
tumorigenesis. Endocr Rev. 28:165–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang E, Liu S, Xu Z, Huang S, Tan X, Sun
C and Lu L: Pituitary tumor-transforming gene 1 (PTTG1) is
overexpressed in oral squamous cell carcinoma (OSCC) and promotes
migration, invasion and epithelial-mesenchymal transition (EMT) in
SCC15 cells. Tumour Biol. 35:8801–8811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orian-Rousseau V: CD44, a therapeutic
target for metastasising tumours. Eur J Cancer. 46:1271–1277. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lv L, Liu HG, Dong SY, Yang F, Wang QX,
Guo GL, Pan YF and Zhang XH: Upregulation of CD44v6 contributes to
acquired chemoresistance via the modulation of autophagy in colon
cancer SW480 cells. Tumour Biol. 37:8811–8824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rice TW, Gress DM, Patil DT, Hofstetter
WL, Kelsen DP and Blackstone EH: Cancer of the esophagus and
esophagogastric junction-Major changes in the American Joint
Committee on Cancer eighth edition cancer staging manual. CA Cancer
J Clin. 67:304–317. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yan L, Zucker S and Toole BP: Roles of the
multifunctional glycoprotein, emmprin (basigin; CD147), in tumour
progression. Thromb Haemost. 93:199–204. 2005.PubMed/NCBI
|
|
15
|
Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z,
Huang XF, Chen ZN and Bian H: HAb18G/CD147 promotes
epithelial-mesenchymal transition through TGF-β signaling and is
transcriptionally regulated by Slug. Oncogene. 30:4410–4427. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhu S, Li Y, Mi L, Zhang Y, Zhang L, Gong
L, Han X, Yao L, Lan M, Chen Z and Zhang W: Clinical impact of
HAb18G/CD147 expression in esophageal squamous cell carcinoma. Dig
Dis Sci. 56:3569–3576. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou C, Liu S, Zhou X, Xue L, Quan L, Lu
N, Zhang G, Bai J, Wang Y, Liu Z, et al: Overexpression of human
pituitary tumor transforming gene (hPTTG), is regulated by
beta-catenin/TCF pathway in human esophageal squamous cell
carcinoma. Int J Cancer. 113:891–898. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shah PP, Fong MY and Kakar SS: PTTG
induces EMT through integrin αVβ3-focal adhesion kinase signaling
in lung cancer cells. Oncogene. 31:3124–3135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shah PP and Kakar SS: Pituitary tumor
transforming gene induces epithelial to mesenchymal transition by
regulation of Twist, Snail, Slug, and E-cadherin. Cancer Lett.
311:66–76. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang J, Yang Y, Chen L, Zheng D and Ma J:
Overexpression of pituitary tumor transforming gene (PTTG) is
associated with tumor progression and poor prognosis in patients
with esophageal squamous cell carcinoma. Acta Histochem.
116:435–439. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao H, Zhong F, Xie J, Peng J and Han Z:
PTTG promotes invasion in human breast cancer cell line by
upregulating EMMPRIN via FAK/Akt/mTOR signaling. Am J Cancer Res.
6:425–439. 2016.PubMed/NCBI
|
|
22
|
Saito S, Okabe H, Watanabe M, Ishimoto T,
Iwatsuki M, Baba Y, Tanaka Y, Kurashige J, Miyamoto Y and Baba H:
CD44v6 expression is related to mesenchymal phenotype and poor
prognosis in patients with colorectal cancer. Oncol Rep.
29:1570–1578. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kunishi M, Kayada Y and Yoshiga K:
Down-regulated expression of CD44 variant 6 in oral squamous cell
carcinomas and its relationship to regional lymph node metastasis.
Int J Oral Maxillofac Surg. 26:280–283. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nieto MA, Huang RY, Jackson RA and Thiery
JP: EMT: 2016. Cell. 166:21–45. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li L, Tang W, Wu X, Karnak D, Meng X,
Thompson R, Hao X, Li Y, Qiao XT, Lin J, et al: HAb18G/CD147
promotes pSTAT3-mediated pancreatic cancer development via CD44s.
Clin Cancer Res. 19:6703–6715. 2013. View Article : Google Scholar : PubMed/NCBI
|
